| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.088 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.081 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |